SRPW Consulting

Reduce investment risk. Scale real-world performance.


Strong clinical and technical evidence proves a product can work. Whether it delivers value in the real world depends on something else entirely.

That's where we focus.

Most performance gaps aren't clinical or technical — they're behavioral. Understanding how consumers think, decide, and act in real-world contexts is what separates products that succeed from those that fall short. And that's precisely where the greatest performance gains are found.

I help pharmaceutical and health technology teams identify how consumer factors influence product performance, translate that evidence into strategic decisions, and build the solutions and measurement systems to accelerate value.

Let's work together

Delivered across my industry career

1M+ People influenced
90%+ Accuracy matching people to tailored solutions
10+ International markets (EMEA, APAC, LATAM, NA)
$4M+ Funded engagements and partnerships

The right expertise, in the right capacity, at the right time.

The stakes are high, the evidence is complex, and the path forward isn't always clear. That's when teams benefit most from an outside perspective grounded in both science and real-world execution.

I embed, advise, or lead, depending on what the engagement requires.

Together, we connect consumer insights to strategic priorities, informing solutions that reduce investment risk and accelerate scale.

AI & Generative Technologies

Digital Companions & Applications

Precision Patient & Provider Education

Oncology Maternal Health Cardiovascular Health Psychiatry Mental Health Vaccines Clinical Trial Recruitment Clinical Guideline Adoption Oncology Maternal Health Cardiovascular Health Psychiatry Mental Health Vaccines Clinical Trial Recruitment Clinical Guideline Adoption

Evidence, solutions, and measurement systems your product needs to perform.

Without this intelligence, teams risk investing in markets and populations where the conditions for success aren't yet in place. Together, we identify the behavioral and contextual factors that determine where your product will gain traction and where it won't, before you commit.

A controlled setting rarely reflects the complexity of broader markets. The gap is almost always socio-behavioral. Together, we identify the specific risks before you commit to scale, so you're building on evidence, not assumptions.

When results fall short, the reasons are rarely on the surface. We diagnose exactly where performance is breaking down, for whom, and why, then build the solution and measurement system to address it.

Data that doesn't change decisions isn't doing its job. We build the outcome attribution systems and decision tools that make performance intelligence actionable, connecting what's happening in the real world to the decisions that matter most.

The rigor of a scientist. The strategy and execution of an operator.

Success is measured by whether products deliver value in the real world. Engagement is a signal. Performance is the goal.

Technical and organizational constraints are real. We work within existing products, workflows, and systems, building on what works rather than recommending overhauls that create new risk.

Evidence is only as valuable as the decisions it informs. We translate science into strategies, requirements, and measurement approaches teams can use immediately.

The patterns that explain performance gaps in pharma often have parallels in Big Tech, startups, and social impact. We bring those connections to every engagement.

You work directly with me, with additional expertise brought in when the engagement requires it.

Samantha is one of those scientists and strategists who translates rigorous thinking into deliverables that actually moves a business forward. Her reputation precedes her and her work speaks for itself.

Director of Social Impact Technology, Fortune 50 Pharma

She came in, assessed what we needed, and built something we could actually use. She worked alongside our team rather than handing off a report and presentation. It's a repeatable framework our global partners are slated to apply across multiple markets and use cases. That's not easy to do.

Health Solutions Lead, Big 5 Tech

I'd describe her as systematic, thorough, and pragmatic. She gave us a clearer picture of our target market, a sharper sense of what to build, and the measurement approach we need to justify the investment. She offers clarity and useful deliverables.

R&D Lead, Fortune 100 Pharma

She came in, understood exactly what we needed, and delivered a clear strategy with timelines and next steps that got a stalled initiative moving again.

Medical Affairs Lead, Fortune 100 Pharma

She transformed a complex initiative into a clear value story that helped executives secure a $2M investment partnership. Her ability to identify the right data, explain its importance, and translate it into action is rare.

Executive Lead, National Non-Profit

I'm a behavioral scientist and industry strategist focused on closing the gap between what products are designed to do and how they perform in the real world.

Across global pharma, Big Tech, tech startups, and social impact organizations, I've seen the same pattern: technical excellence is necessary but not sufficient. Products succeed when teams understand the people, behaviors, and contexts that shape real-world use, and when that understanding is built into the product from the start.

I've worked across multiple international markets and cross-therapeutic areas, bridging scientific rigor and pragmatic execution to help teams make better decisions, reduce investment risk, and scale products that deliver value.

Selected training and certifications across my industry career:

Samantha R. Paige, PhD, MPH

Samantha R. Paige, PhD, MPH

Founder, SRPW Consulting, LLC

10+ Years of Experience
70+ Publications
F50 Tech & Pharma
Partners

Your product is built to deliver value.
Together, we'll make sure it does in the real world.

Fractional Leadership | Strategic Advisory | Embedded Execution
Let's talk